HDR Brachytherapy vs SABR in Early-intermediate Prostate Cancer

NCT04870567 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

350

Enrollment

OTHER

Sponsor class

Conditions

Biochemical Relapse Free Survival
Complications Rates (Erectile Dysfunction, GI, GU Complications)

Interventions

RADIATION: Stereotactic ablative radiotherapy
RADIATION: High dose rate brachytherapy

Sponsor

N.N. Petrov National Medical Research Center of Oncology